Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS

S. Miyoshi, R. Ito, H. Katayama, K. Irifune, H. Hamada, T. Suwaki, N. Nakanishi, T. Kanematsu, K. Dote, M. Aibiki, J. Higaki (Toon, Hiroshima, Niihama, Matsuyama, Japan)

Source: Annual Congress 2012 - How to use technology to provide better critical care
Session: How to use technology to provide better critical care
Session type: Oral Presentation
Number: 395
Disease area: Respiratory critical care

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Miyoshi, R. Ito, H. Katayama, K. Irifune, H. Hamada, T. Suwaki, N. Nakanishi, T. Kanematsu, K. Dote, M. Aibiki, J. Higaki (Toon, Hiroshima, Niihama, Matsuyama, Japan). Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS. Eur Respir J 2012; 40: Suppl. 56, 395

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Source: Eur Respir J 2012; 40: 1475-1482
Year: 2012



Effect of neutrophil elastase inhibitor (ONO-5046) and gabexate mesilate on acid-induced lung injury in rats
Source: Eur Respir J 2006; 28: Suppl. 50, 660s
Year: 2006

Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008

The feasibility of neutrophil elastase inhibitor in the treatment of acute lung injury of post pneumonectomy patients
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010

Neutrophil elastase inhibitor sivelestat ameliorates gefitinib, naphthalene-induced acute pneumonitis in mice
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015


Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003



Inhibition of neutrophil elastase contributes to attenuationof lipopolysaccharide-induced acute lung injuryduring neutropenia recovery in mice
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Neutrophil elastase and IL-8 assessment in patients with COPD and asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 61s
Year: 2005

Human neutrophil elastase in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 24s
Year: 2004

Pentoxifylline inhibits the neutrophil alveolitis in a murine ARDS model
Source: Eur Respir J 2001; 18: Suppl. 33, 238s
Year: 2001

Increased intraalveolar levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with interstitial lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 586s
Year: 2002

Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001

Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014

Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018


Role of thrombin-activatable fibrinolysis inhibitor in lipopolysaccharide-induced acute lung injury
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011

CINC-1 concentration and neutrophil elastase activity are increased in rat ventilator-induced lung injury
Source: Eur Respir J 2003; 22: Suppl. 45, 460s
Year: 2003